COVID-19 and cognitive impairment: neuroinvasive and blood‒brain barrier dysfunction - Journal of Neuroinflammation

  • 📰 BioMedCentral
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 71%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

A Review published in the Journal of Neuroinflammation assesses the potential involvement of neuroinvasion and blood‒brain barrier dysfunction in SARS-CoV-2 infection, and explores its impact on COVID-19-related cognitive dysfunction. LongCovid

]. Therefore, some patients with COVID-19 are expected to develop long-term neurocognitive sequelae after the acute disease has resolved. In general, the chronic cognitive sequelae of ischaemia and hypoxia can range from mild attention and memory impairment to general cognitive decline and dementia and even coma.Growing evidence suggested that survivors of COVID-19 suffer from neurological involvement. The brain is undoubtedly one of the targets of COVID-19.

Notably, it is important for SARS-CoV-2 models to reliably test the molecular and functional consequences of infection and drug treatment strategies via the establishment of a high paracellular tightness in vitro that is comparable to physiological conditions in vivo. Currently, the link between BBB leakage and cognitive decline is poorly understood, and more research is needed to further define this link.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 22. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+ and CD4+ T cells of broad specificity | Journal of Experimental Medicine | Rockefeller University PressVirus-specific T cells in the nasal cavity might provide an immediate layer of protection against SARS-CoV-2. This study detected SARS-CoV-2–specific nasal-resi
Source: medical_xpress - 🏆 101. / 51 Read more »